WE BUILD CAPABILITIES TO DRIVE EXCELLENCE
Capabilities to support businesses in their quest for incisive research and actionable insights
We love the challenges
…that come with trying to understand niche sectors, remote frontier markets and constantly evolving market dynamics. What makes it equally interesting is the way we work, as one non-hierarchical multi-cultural global team, unhindered by physical location, time zones or cultural differences.
We are not a research factory
…and that is our strength. Each analyst in the team has an equal opportunity to learn, discover, grow and excel at what we do best – deliver insights to power informed decision-making.
We offer dynamic and motivating work environment
…with flexible work options, using modern communication tools to brainstorm with team members and working together to deliver quality intelligence to our growing portfolio of clients.
We are strongly committed
…to our social responsibility and have supported causes of education and environment at large. Beyond work, members of our team passionately pursue a range of activities from adventure sports, photography, off-the-beaten path travel, to culinary tourism.
excellence. integrity. respect
what we believe in and what we strive for
JOIN EOS
We don’t have any open positions and aren’t actively seeking applications at the moment. If you would still like to share your credentials, drop us a note, and we will get back to you.
Follow us to stay informed about future openings.
Latest Perspectives
- Estonia’s Rise as Europe’s Fintech Powerhouse
- Japan’s EV Hesitation: The High Cost of Delay to Its Automotive Sector
- Open Banking Sparking a Wave of Innovation in Financial Services
- Continuous Glucose Monitoring Devices: Overcoming Barriers in LMICs
- The Future of Diabetes Care: Key Innovations in the Continuous Glucose Monitoring
- NVIDIA’s Meteoric Rise: Can the AI Chip Giant Sustain Its Dominance?
- Mind over Matter: How Non-invasive Neuromodulation Is Becoming the Future of Pain Management and Beyond
- New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?
- Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?
- Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints
- Neuromarketing: How Brands Are Leveraging Brain Science to Decode Your Desires
- What’s Fueling Asia’s Drive to Develop Wholesale CBDCs?
- Prescribing Security: Diagnosing and Treating the IoT Universe in Healthcare
- Lessons for Africa: To-do’s from India’s Successful Vaccine Journey
- Why Can India’s Vaccine Success Story Be a Sure Shot Template for Africa?
- Charting the RegTech Journey: Navigating Consolidation
- Pet Wearables – Are Companies Barking Up the Right Technology?
- IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?
- The Rise and Fall of Cue Health: Market Lessons and Implications
- Denmark – A Trailblazer in Digital Health Innovation